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Abstract
Background: The increased potential for negative pregnancy outcomes in both extremes of reproductive age is
a well-debated argument. The aim of this study was to analyze the prevalence and the outcome of pregnancies
conceived at extreme maternal ages.
Methods: This retrospective study considered all single consecutive pregnancies delivered in a tertiary referral
center between 2001 and 2014. Patients were categorized into 4 groups according to maternal age at
delivery (< 17 years; 18–28 years; 29–39 years; > 40 years). The following outcomes were considered (amongst
others): pregnancy-related hypertensive disorders (PRHDs), neonatal resuscitation (NR), neonatal intensive care
unit (NICU) admission, periventricular leucomalacia (PVL), and grade 3 and 4 intraventicular hemorrhage (IVH).
Results: During the considered period 22,933 single pregnancies gave birth in our unit. We observed 71 women
aged < 17 years, and 1552 aged > 40 years. In each year throughout the study period, there was a significant
increment in maternal age of 0.041 years (95% CI 0.024–0.058) every new year. Multivariate analysis concluded out
that maternal age over 40 years was an independent risk factor for preterm delivery (OR 1.36 95% CI 1.16–1.61,
p < 0.05, PRHDs (OR 2.36 95% CI 1.86–3.00, p < 0.05), GDM (OR 1.71 95% CI 1.37–2.12, p < 0.05) cesarean section
(OR 1.99 95% CI 1.78–2.23, p < 0.05), abnormal fetal presentation (OR 1.29 95% CI 1.03–1.61, p < 0.05), and fetal
PVL (OR 3.32 95% CI 1.17–9.44, p < 0.05). We also observed that maternal age under 17 years or over 40 years was
an independent risk factor for grade 3 or 4 neonatal IVH (OR 2.97 95% CI 1.24–7.14, p < 0.05).
Conclusions: These findings confirm a negative impact of extreme maternal ages on pregnancy. These results
should be carefully taken into account by maternal care providers in order to inform women adequately, supporting
them in understanding potential risks associated with their procreation choices, and to improve clinical surveillance.
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Background
Maternal age at childbearing has dramatically shifted in the
last decades due to a broad range of social and cultural de-
terminants. In Italy the mean age at delivery rose from 25.2
years in 1981 to 31.7 in 2015 [1, 2]. This trend toward de-
layed childbearing is reported worldwide (e.g. USA or
China) [3–5], and comes, in parallel, with a decline in preg-
nancies at a younger age, so that these are increasingly rare
in developing countries. The teen birth rate in the USA has
fallen 61% from 1991 [5].
Both extremes of the reproductive age are considered at
risk for adverse pregnancy outcomes. Teenage mothers
have a higher risk of preterm birth, low birth weight, low
Apgar score and postnatal mortality [6]. Whether this
association is determined by a biological immaturity or ra-
ther by socio-economic disadvantages, behavioural factors
or lack of access to high quality antenatal care is still a
topic for much discussion. [7–9]. On the other hand de-
layed childbearing carries a higher risk of maternal and
obstetric complications. The concern for the “elderly
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primigravida” was first published in 1950 [10]; since then
many researchers investigated the effect of aging on birth
outcome. The majority of studies report an association be-
tween advanced maternal age and preterm delivery, low
birth weight, perinatal death, and cesarean section [11–
16]. There are some studies, however, that fail to demon-
strate such unfavourable conclusions [4, 17–19]. And an
emerging third category even demonstrates positive out-
comes, with an example being a recent retrospective study
from China which found a lower risk of adverse fetal out-
come for older mothers [4]. The impact of presumed
social and economic advantages of older women out-
weighing biological vulnerability, advocated by some, still
needs to be conclusively proven. It is however worth not-
ing, that although infants born to mothers over 40 years of
age are more frequently admitted to intensive neonatal
care, these pregnancies tend to be associated with im-
proved perinatal care outcomes over time [20, 21].
The aim of this study is to analyze prevalence and out-
come of pregnancies conceived at extreme maternal ages
(age equal or lower than 17 years old and equal or higher
than 40 years old), and to verify the impact of maternal
age on pregnancy outcomes.
Methods
This retrospective study considered 22,933 single con-
secutive pregnancies carried out in our Obstetrics and
Gynecology Clinic in University Hospital Santa Maria
della Misericordia (tertiary referral center). The present
study was approved by the internal review board, it was
conducted in accordance with Helsinki Declaration and
it followed the dictates of the general authorization to
process personal data for scientific research purposes by
the Italian Data Protection Authority. All women who
delivered between January 2001 and December 2014
were eligible to be included in this study. Multiple preg-
nancies were excluded.
Maternal-fetal and neonatal data were gathered from clin-
ical databases of our Obstetric and Neonatal facilities. Pa-
tients were categorized into 4 groups according to maternal
age at delivery (< 17 years; 18–28 years; 29–39 years; > 40
years). Personal data assessed were: maternal age, parity,
assisted reproduction techniques, provenance and edu-
cation level (low schooling was considered below 8
years of study). Pregnancy and neonatal outcomes
assessed were: gestational age at delivery, fetal presenta-
tion, mode of onset of labour, mode of delivery,
pregnancy-related hypertensive disorders (PRHDs), ges-
tational diabetes mellitus (GDM), gestational age at
birth, neonatal length, neonatal cranial circumference,
placental weight, neonatal sex, neonatal weight, apgar
score at first and fifth minute, eventual administration
of prenatal corticosteroid profilaxis, intrauterine growth
restriction (IUGR), small for gestational age (SGA),
large for gestational age (LGA), presence of neonatal
congenital anomalies, neonatal distress syndrome
(RDS), neonatal resuscitation (NR), neonatal intensive
care unit (NICU) admission, periventricular leucomala-
cia (PVL), grade 3 and 4 intraventicular hemorrhage
(IVH), retinopathy of prematurity (ROP), and perinatal
death.
Gestational age was calculated by the date of the last
known menstrual period and confirmed by ultrasound
examination during first and second trimester. The pres-
ence of hypertension was defined as a systolic blood
pressure ≥ 140mmHg or a diastolic blood pressure ≥ 90
mmHg [22, 23]. The following items were grouped as
PRHDs: eclampsia, pre-eclampsia, pre-eclampsia superim-
posed on chronic hypertension, and gestational hyperten-
sion [24, 25]. Pre-eclampsia was defined as hypertension
accompanied by proteinuria first detected after 20 weeks
gestation [22, 23]. Proteinuria was defined as the presence
of urinary protein in concentrations more than 0.3 g in a
24-h period (this usually correlates with 30mg/dl or
greater in a random urine determination). Gestational
hypertension was diagnosed in the same way as pre-
eclampsia, but without proteinuria, and eclampsia was
diagnosed in the same way as pre-eclampsia, but with sei-
zures [22, 23]. Chronic hypertension was diagnosed when
hypertension was present before the 20th week of preg-
nancy [22, 23]. IUGR was defined as the sonographic find-
ing of foetal weight below the tenth percentile of expected
weight for gestational age (using Hadlock formula), linked
with the increased pulsatility index of umbilical artery
greater than two standard deviations, and a post-partum
verification with a foetal weight under the 10th centile at
birth. In this study, SGA and LGA were defined as neo-
natal weight under the 10th and over the 90th percentiles
for gestational age, respectively [26, 27]. Preterm delivery
was defined as delivery occurring before 37 completed
weeks of gestation. Over the course of our study period,
the diabetes screening method was changed. Up until
2010 a universal 50 g oral glucose challenge was per-
formed (as previously described [28]), between 2010 and
2011 the universal screening method changed as previ-
ously described [29, 30], and starting from 2011 gesta-
tional diabetes was diagnosed through the 75-g two-hour
oral glucose tolerance test before or after 24 weeks of ges-
tation in the second trimester according to the presence
of risk factors [30, 31]. All foetuses in breech or abnormal
presentation were delivered by cesarean section. A diagno-
sis of PVL was established on the basis of magnetic reson-
ance imaging findings, routinely performed on the basis of
Volpe’s study [32]. Grade 3 and 4 intraventicular
hemorrhage (IVH) were diagnosed using cranial ultra-
sound and classified according to Papile’s definitions [33].
ROP was diagnosed by an experienced ophtamologist and
classified according to the international classification of
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ROP [34]. Perinatal death was defined as death that occurs
at less than 28 days of age and fetal deaths at a gestational
age of 20 weeks or more [35].
Statistical analysis was performed using R software
(version 3.4.1; R Core Team (2017). R: A language and
environment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria. URL https://
www.R-project.org/.). P < 0.05 was considered statisti-
cally significant. Data are presented as median and inter-
quartile range (IQR) for continuous non parametric
variables; mean ± standard deviation for continuous
parametric variables. Dicotomic variables were coded as
percentage and absolute values, except for missing
values (NA). The results of logistic regression models
were presented as odds ratio (OR) at 95% confidence
interval (CI). The distribution of continuous variables
was evaluated with Kolmogorov-Smirnov test to detect
whether the distribution was normal or not. For con-
tinuous variables the following statistical tests were
employed: t-test for parametric variables and Wilcoxon
test for continuous non parametric variables. Subse-
quently, logistic regression analysis was performed, con-
sidering established outcomes as dependent variables
and the possible risk factors for such outcome as inde-
pendent variables. In the multivariate model we took
into account all possible predictive factor with p < 0.200
in univariate analysis. The Initial multivariate model in-
cluded all variables and their interactions. When interac-
tions turned out to be non significant, analysis without
interaction model was used. In addition, the p-values of
the multivariate analysis were adjusted using the false
discovery rate test.
Results
During the considered period 22,933 single pregnancies
gave birth in our unit. The mean maternal age at deliv-
ery was 31.88 years (±5.38) and 55.88% of women were
nulliparous. We recorded 71 women aged < 17 years,
5714 aged between 18 and 28 years, 15591 aged between
29 and 39 years, and 1552 aged > 40 years. Figure 1a
shows the consistent increase of pregnant women over
40 years of age in our population from 2001, as well as
the low prevalence of pregnancies in patients younger
than 17 years of age. Figure 1b and c depict the yearly
mean age at delivery, which was constantly rising, and
the contribution of nulliparous and multiparous women
(Fig. 1c). In particular there was a significant increase in
maternal age by 0.041 years (95% CI 0.024–0.058) in
each year of the study.
Table 1 reports the characteristics of the population.
Two elements were particularly relevant: preterm deliv-
eries and PRHDs occurred more frequently among older
women. In addition, low schooling was more frequent
among younger women. Tables 2 and Additional file 1:
Table S1 describe labour and delivery (in both global
population and nulliparous women). It is worth noting
that as maternal age increased, spontaneous labour and
delivery declined significantly. GDM and abnormal fetal
presentations (including breech presentation) were also
more common among older women. Fetal outcomes are
presented in Table 2 and Additional file 2: Table S2.
Women over 40 years demonstrated a higher prevalence
of RDS, grade 3 or 4 inter-ventricular hemorrhage, peri-
ventricular leucomalacia, neonatal cardio-pulmunar re-
suscitation, neonatal death and IUGR. In mothers under
17 years we observed a lower neonatal weight MoM and
a greater incidence of grade 3 or 4 IVH.
Maternal age was an independent risk factor for the
considered variables in multivariate analysis, as ex-
plained in Tables 3 and 4. In conclusion, multivariate
analysis showed that maternal age over 40 years was an
independent risk factor for preterm delivery, PRHDs,
GDM, abnormal fetal presentation, cesarean section, and
fetal PVL. We also observed that maternal age under 17
years or over 40 years was an independent risk factor for
grade 3 or 4 neonatal IVH. Also after adjustment of the
multivariate analysis p-values with the false discovery
rate test maternal age over 40 years remained a signifi-
cant risk factor for many of the previously listed out-
comes, only fetal PVL p-value shifted slightly above the
significant threshold.
Discussion
Our study shows an increasing prevalence of mothers
aged over 40 years. This is consistent with Italian and
European demographic data, in which Italy ranks as one
of the top countries for high maternal mean age at birth
of the first child [1, 2]. In all developed countries, the
deep social and economic transformations of recent de-
cades have led to higher life standards together with a
deferment of parenthood [3–5, 36]. This phenomenon is
due to multiple determinants: global aging of population
with an increasing prevalence of women aged between
35 and 45 years, the change in social customs with a rise
in divorces and second marriages, improvements to
women’s educational and professional outlooks as well
as the diffusion of contraception. The availability of
contraception has made women protagonists of their
childbearing options. Asked to explain the main deter-
minants of their pregnancy plan, a survey group of
women mentioned educational and career achievements,
financial goals and emotional stability, illustrating how
individual readiness seems to be an essential factor in
guiding childbearing options [37].
In our study the incidence of PRHDs is higher as ma-
ternal age increases. This is in line with the findings of
other studies. In a retrospective analysis of 8′079’996 live
births of singletons the adjusted odds ratio of pregnancy




Fig. 1 a Time trend of the age groups analyzed during the study period. b Time trend of Average age and relative standard deviation. c Time
trend of Average age and relative standard deviation in nulliparous and pluriparous women
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associated hypertension for women ≥45 years, compared
with women aged 30–34, was 1.55 and 2.13 respectively
for primiparas and multiparas [38]. Another case control
study found a significantly higher rate of preeclampsia in
women over 45 years compared to the control group
(10.7% versus 1.8% respectively) [39].
The higher risk of developing GDM with advancing
age that we confirmed is widely reinforced in literature,
and can be explained by the progressive depletion of
pancreatic β-cell function that leads to a reduced insulin
sensitivity. This data justifies the universal screening in
all pregnant women over 35 years old that we currently
apply [15, 38, 39].
Maternal age over 40 years is an independent risk fac-
tor for preterm delivery. This data was reported in vari-
ous population-based studies [40–42]. Swedish research
studying 2′009’068 birth found that advanced maternal
age is associated with an increased risk of preterm birth,
especially very preterm birth, irrespective of parity, (ad-
justed ORs 1.18 to 1.28 at 30–34 years, from 1.59 to 1.70
at 35–39 years, and from 1.97 to 2.40 at ≥40 years) [43].
Another population based cohort study from Sweden
restricted to 173,715 healthy women with a single preg-
nancy, reported increasing adjusted odds ratios for pre-
term delivery with increasing maternal age, after
adjusting for demographic characteristics, smoking, his-
tory of infertility, and other medical conditions [44]. The
underling reasons are not clear. One of the mechanisms
that could be involved is placental vascular pathology. In
fact, spontaneous preterm birth has been associated with
a four- to seven-fold increased risk of histological evi-
dence of placental bleeding, loss of vessel integrity and
lack of physiologic conversion of maternal spiral arteries
[45]. Preeclampsia and hypertensive disorders are also
associated with uteroplacental ischemia and with pre-
term birth. As we illustrated, older women have a higher
risk of both these complications, and are also more
likely to have a IUGR, which is also vascular-mediated.
Another possible actor in the pathway of preterm birth
in older women is progesterone deficiency: progesterone
levels decrease with maternal age. Low levels of this
hormone are associated with preterm delivery and pro-
gesterone supplementation has been proven to be effect-
ive in preventing it [46].
We demonstrated a lower prevalence of labour and
spontaneous delivery in women of advanced age, and a
higher rate of cesarean section. A lot of other studies
came to similar conclusions [47–51]. In a retrospective
cohort study of mothers aged 45 years or more the
cesarean section rate was 49% compared to 23% in the
20–29 year age group (p < 0.001) [47]. In another retro-
spective analysis, among 77 women aged 50 years or
older, who conceived after in vitro fertilization with
donor oocytes, 68% were delivered by cesarean section
Table 1 Characteristics of the study population categorised by age group
< 17 years (71) 18–28 years (5714) 29–39 years (15591) > 40 years (1552) p
Maternal age (years) 16.52 (±0.63) 24.86 (±2.70) 33.59 (±2.89) 41.34 (±1.60) 1,2,3,4,5,6
Nulliparous women 98.55% (68/69) 69.84% (3858/5524) 52.31% (7897/15097) 38.22% (571/1494) 1,2,3,4,5,6
Low schooling 76.06% (54/71) 34.06% (1946/5714) 18.27% (2848/15591) 20.30% (315/1552) 1,2,3,4,5,6
Conception mode
Spontaneous 98.59% (70/71) 99.46% (5683/5714) 98.40% (15342/15591) 96.13% (1492/1552) 4,5,6
Ovulation induction/IUI 1.41% (1/71) 0.35% (20/5714) 0.59% (92/15591) 0.52% (8/1552) 4
IVF/ICSI 0.00% (0/71) 0.19% (11/5714) 1.01% (157/15591) 3.35% (52/1552) 4,5,6
Gestational age at delivery
(weeks)
38.80 (±2.56) 38.69 (±2.64) 38.61 (±2.50) 38.17 (±2.68) 3,4,5,6
Delivery < 32 weeks 2.82% (2/71) 3.65% (208/5705) 3.02% (470/15547) 3.80% (59/1552) 4
Delivery < 34 weeks 2.82% (2/71) 4.93% (281/5705) 4.55% (707/15547) 5.86% (91/1552) 6
Delivery < 37 weeks 8.45% (6/71) 9.87% (563/5705) 9.90% (1539/15547) 13.92% (216/1552) 5,6
Macro-region of origin
Europe/Italy 80.00% (56/70) 81.29% (4637/5704) 92.03% (14339/15581) 94.71% (1469/1551) 2,3,4,5,6
Sub-Saharian Africa 12.86% (9/70) 6.54% (373/5704) 3.61% (562/15581) 2.45% (38/1551) 1,2,3,4,5,6
Arabian countries 1.43% (1/70) 5.84% (333/5704) 1.93% (301/15581) 1.42% (22/1551) 4,5
Other origin 5.71% (4/70) 6.33% (361/5704) 2.43% (379/15581) 1.42% (22/1551) 3,4,5,6
PRHDs 0.00% (0/71) 2.22% (127/5714) 2.51% (391/15591) 5.41% (84/1552) 3,5,6
GDM 0.00% (0/71) 2.54% (145/5714) 4.28% (667/15591) 6.44% (100/1552) 3,4,5,6
Acronyms: IUI Intrauterine insemination, IVF In vitro fertilization, ICSI Intracytoplasmatic sperm injection, PRHD Pregnancy related hypertensive disorder, GDM
Gestational diabetes mellitus. Different numbers indicate statistically significant differences (p < 0.05): (1) < 17 years vs 18–28 years; (2) < 17 years vs 29–39 years;
(3) < 17 years vs > 40 years; (4) 18–28 years vs 29–39 years; (5) 18–28 years vs > 40 years; (6) 29–39 years vs > 40 years. NS= no significant difference
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[51]. Another paper that reviewed 24′032 pregnancies of
women who delivered at age 40 or over, illustrated a
higher risk of operative delivery (cesarean, forceps, and
vacuum deliveries): 61% compared to the 35% in youn-
ger nulliparous women, in spite of lower birth weight
and gestational age [50]. In a cohort study on 78′880
singleton births in the United States, which excluded pa-
tients with prior cesarean section, the proportions and
the risks of primary cesarean section increased with age
in spite of parity [49]. The reasons for the high rate of
operative delivery in older women are controversial. In
our sample a higher rate of cesarean section in older
women remains even after controlling for labour
induction and exluding abnormal fetal presentations,
suggesting that beyond comorbilities other factors im-
pact on this surgical intervention. Labour distocia has
been reported to be significantly higher in advanced age
[52]. The correlation between uterine dysfunction and
age has already been studied, and seems to have a linear
increase during childbearing years [53]. In particular our
data confirms a significant association between abnor-
mal fetal presentation and older age [54], which could
also be due to impaired placentation correlated with ad-
vanced maternal age [45, 55].
A maternal age over 40 years was an independent risk
factor for fetal PVL. An age either below 17 years or over
40 years was an independent risk factor for grade 3 or 4
neonatal IVH. These results describe a previously
Table 2 Labor, delivery, and neonatal characteristics and neonatal outcomes
< 17 years (71) 18–28 years (5714) 29–39 years (15591) > 40 years (1552) p
Labor and delivery
Abnormal fetal presentation 4.23% (3/71) 4.34% (248/5713) 5.33% (831/15590) 6.12% (95/1552) 4,5
Mode of labor
Spontaneous 71.21% (47/66) 68.10% (3399/4991) 63.22% (8478/13411) 52.95% (726/1371) 3,4,5,6
Induced/augmented 19.70% (13/66) 22.30% (1113/4991) 21.19% (2842/13411) 19.69% (270/1371) 5
Without labor 9.09% (6/66) 9.60% (479/4991) 15.59% (2091/13411) 27.35% (375/1371) 3,4,5,6
Childbirth mode
Operative vaginal delivery 5.63% (4/71) 8.58% (490/5714) 7.25% (1130/15591) 5.73% (89/1552) 4,5,6
Spontaneous delivery 77.46% (55/71) 67.12% (3835/5714) 60.77% (9474/15591) 48.84% (758/1552) 2,3,4,5,6
Caesarean section 16.90% (12/71) 24.31% (1389/5714) 31.99% (4987/15591) 45.43% (705/1552) 2,3,4,5,6
Caesarean section in labour 8.33% (5/60) 14.30% (645/4512) 16.72% (1893/11320) 22.09% (220/996) 3,4,5,6
Neonatal charateristics and outcomes
RDS prophylaxis
Not performed 97.18% (69/71) 96.04% (5488/5714) 96.34% (15020/15591) 94.33% (1464/1552) 5,6
Uncompleted 2.82% (2/71) 0.88% (50/5714) 0.66% (103/15591) 0.84% (13/1552) 2
Completed 0.00% (0/71) 3.08% (176/5714) 3.00% (468/15591) 4.83% (75/1552) 5,6
Neonatal male sex 49.30% (35/71) 51.40% (2937/5714) 50.86% (7930/15591) 51.29% (796/1552) NS
1st minute Apgar score 8.00 (8.00–9.00) 8.00 (8.00–9.00) 8.00 (8.00–9.00) 8.00 (8.00–9.00) NS
5th minute Apgar score 9.00 (9.00–9.00) 9.00 (9.00–9.00) 9.00 (9.00–9.00) 9.00 (9.00–9.00) NS
Neonatal congenital malformation 4.23% (3/71) 1.38% (79/5714) 1.50% (234/15591) 2.06% (32/1552) 1
RDS 7.04% (5/71) 5.71% (326/5714) 5.71% (890/15591) 7.80% (121/1552) 5,6
Retinopathy of prematurity 1.41% (1/71) 0.82% (47/5714) 0.90% (140/15591) 1.10% (17/1552) NS
3rd 4th degree IVH 1.41% (1/71) 0.26% (15/5714) 0.19% (29/15591) 0.52% (8/1552) 2,6
Periventricular leucomalacia 0.00% (0/71) 0.16% (9/5714) 0.08% (12/15591) 0.32% (5/1552) 6
NR 5.63% (4/71) 3.45% (197/5714) 3.30% (515/15588) 4.38% (68/1552) 6
NICU hospitalization 0.00% (0/71) 0.02% (1/5711) 0.03% (5/15582) 0.00% (0/1551) NS
Perinatal death 0.00% (0/71) 0.93% (53/5714) 0.74% (116/15591) 1.16% (18/1552) NS
IUFD 0.00% (0/71) 0.30% (17/5714) 0.37% (58/15591) 0.45% (7/1552) NS
Neonatal death 0.00% (0/71) 0.63% (36/5714) 0.37% (58/15591) 0.71% (11/1552) 4,6
Acronyms: RDS Respiratory distress syndrome, IVH Intraventricular hemorrhage, NR Neonatal resuscitation, NICU Neonatal intensive care unit, IUFD Intrauterine fetal
demise. Different numbers indicate statistically significant differences (p < 0.05): (1) < 17 years vs 18–28 years; (2) < 17 years vs 29–39 years; (3) < 17 years vs > 40
years; (4) 18–28 years vs 29–39 years; (5) 18–28 years vs > 40 years; (6) 29–39 years vs > 40 years. NS= no significant difference
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Table 3 Risk factors for the following specified pregnancy outcomes considered as dependent variables: delivery < 37 weeks’
gestation; pregnancy related hypertensive disorders; and caesarean section. Possible risk factors were considered as independent
variables. Univariate and multivariate (*) logistic regression analysis were performed. (**) Excluded from the analysis non cephalic
fetal presentation. (#) p-value corrected for the false discovery rate test
OR (CI95%) p OR (CI95%) (*) p (*) p(#)
Delivery < 37 weeks’ gestation
Maternal age > 40 years 1.47 (1.27–1.71) < 0.05 1.36 (1.16–1.61) < 0.05 < 0.05
Nulliparous women 1.26 (1.16–1.38) < 0.05 1.31 (1.19–1.44) < 0.05 < 0.05
Conception via assisted reproductive
techniques
1.53 (1.13–2.07) < 0.05 1.24 (0.9–1.72) 0.180 0.184
PRHDs (ŧ) 10.82 (9.16–12.78) < 0.05 12.25 (10.02–14.99) < 0.05 < 0.05
Low schooling (ŧ) 1.25 (1.14–1.38) < 0.05 1.31 (1.17–1.46) < 0.05 < 0.05
Macro-region of origin
Europe/Italy Reference Reference
Sub-Saharian Africa 1.43 (1.19–1.73) < 0.05 1.19 (0.97–1.47) 0.090 0.106
Arabian countries 0.75 (0.56–1) < 0.05 0.75 (0.55–1.01) 0.060 0.077
Other origin 1.38 (1.11–1.71) < 0.05 1.35 (1.08–1.69) < 0.05 < 0.05
Pregnancy related hypertensive disorders
Maternal age > 40 years 2.32 (1.83–2.94) < 0.05 2.36 (1.86–3.00) < 0.05 < 0.05
Nulliparous women 1.07 (0.91–1.26) 0.439
Conception via assisted reproductive
techniques
2.4 (1.53–3.75) < 0.05 2.28 (1.45–3.58) < 0.05 < 0.05
Low schooling 1.53 (1.28–1.82) < 0.05 1.4 (1.17–1.69) < 0.05 < 0.05
Sub-Saharian Africa origin 2.73 (2.08–3.58) < 0.05 2.53 (1.91–3.36) < 0.05 < 0.05
GDM
Maternal age > 40 years 1.74 (1.41–2.16) < 0.05 1.71 (1.37–2.12) < 0.05 < 0.05
Nulliparous women 0.71 (0.62–0.82) < 0.05 0.74 (0.64–0.84) < 0.05 < 0.05
Conception via assisted reproductive
techniques
2.02 (1.35–3.03) < 0.05 2.12 (1.4–3.19) < 0.05 < 0.05
Low schooling 1.08 (0.93–1.27) 0.309
Macro-region of origin
Europe/Italy Reference Reference
Sub-Saharian Africa 1.44 (1.08–1.91) < 0.05 1.44 (1.08–1.93) < 0.05 < 0.05
Arabian countries 1.5 (1.07–2.11) < 0.05 1.49 (1.05–2.1) < 0.05 < 0.05
Other origin 1.35 (0.97–1.87) 0.077 1.33 (0.94–1.86) 0.104 0.104
Abnormal fetal presentation
Maternal age > 40 years 1.22 (0.98–1.52) 0.068 1.29 (1.03–1.61) < 0.05 < 0.05
Nulliparous women 1.53 (1.35–1.73) < 0.05 1.52 (1.34–1.73) < 0.05 < 0.05
Conception via assisted reproductive
techniques
1.94 (1.34–2.8) < 0.05 1.65 (1.14–2.39) < 0.05 < 0.05
Arabian countries origin 0.37 (0.21–0.64) < 0.05 0.37 (0.21–0.66) < 0.05 < 0.05
Caesarean section (**)
Maternal age > 40 years 2.03 (1.82–2.27) < 0.05 1.99 (1.78–2.23) < 0.05 < 0.05
Nulliparous women 1.01 (0.95–1.07) 0.774
Conception via assisted reproductive
techniques
1.68 (1.34–2.12) < 0.05 1.52 (1.20–1.93) < 0.05 < 0.05
PRHDs (ŧŧ) 4.74 (3.97–5.65) < 0.05 29.6 (10.72–81.70) < 0.05 < 0.05
Low schooling 1.07 (1.00–1.15) < 0.05 1.02 (0.95–1.10) 0.610 0.612
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unknown important impact of maternal age on neonatal
morbidity that, to our knowledge, we disclose for the
first time. The pathogenesis of IVH is linked to the fra-
gility of the germinal matrix in immature preterm
infants, on which an alteration of cerebral blood flow re-
lated to hypoxia-ischemia and reperfusion intervenes
[56]. Therefore, we hypothesize that the implied mechan-
ism in women at the extremes of childbearing age has,
again, a vascular origin. In fact, an impaired vascular adap-
tation has been considered also in adolescent pregnancies
[57]. Physical immaturity in younger mothers would be an
obstacle to the physiological placental invasion through
multiple pathways: an incomplete estrogen-dependent
growth of the uterus, a residual ontogenetic progesterone
resistance and a deficient tissue specific programming of
immune cells.
The main limitation of this study is its retrospective
design. Meanwhile, its strengths lie firstly in the fact that
it allows the possibility to take important confounding
factors into account, and secondly that clinical manage-
ment was handled by the same team following the same
obstetrical and neonatal policies to manage all cases. In
addition, in comparison to recent literature where the
mean age observed was 30.65 years (95% CI 28.56–
32.75) [11, 12, 17, 39, 43, 49], our study with a mean
maternal age of 31.88 years (±5.38) better contributes to
evidence-based knowledge of possible risk factors of de-
layed childbearing in a aging population.
Table 3 Risk factors for the following specified pregnancy outcomes considered as dependent variables: delivery < 37 weeks’
gestation; pregnancy related hypertensive disorders; and caesarean section. Possible risk factors were considered as independent
variables. Univariate and multivariate (*) logistic regression analysis were performed. (**) Excluded from the analysis non cephalic
fetal presentation. (#) p-value corrected for the false discovery rate test (Continued)
OR (CI95%) p OR (CI95%) (*) p (*) p(#)
Sub-Saharian Africa origin 1.61 (1.45–1.79) < 0.05 1.63 (1.46–1.82) < 0.05 < 0.05
Induced/augmented labor 0.97 (0.89–1.05) 0.400
Neonatal weight (MoM) (ŧŧ) 0.68 (0.55–0.85) < 0.05 0.89 (0.71–1.12) 0.330 0.379
Acronyms: PRHD Pregnancy related hypertensive disorder, MoM Multiple of median. Interaction terms: (ŧ) Interaction term for PRHDs and Low schooling OR 0.56
(CI95% 0.39–0.81) (p < 0.05); (ŧŧ) Interaction term for PRHDs and neonatal weight MoM OR 0.13 (CI95% 0.05–0.37)
Table 4 Risk factors for the following specified neonatal outcomes considered as dependent variables: Fetal PVL and fetal IVH (3rd-
4th degree). Possible risk factors were considered as independent variables. Univariate and multivariate (*) logistic regression analysis
was performed. (#) p-value corrected for the false discovery rate test
OR (CI95%) p OR (CI95%) (*) p (*) p(#)
Fetal PVL
Maternal age > 40 years 3.29 (1.24–8.73) < 0.05 3.32 (1.17–9.44) < 0.05 0.056
Nulliparous women 0.92 (0.43–1.99) 0.835
Conception via assisted reproductive
techniques
2.65 (0.36–19.65) 0.339
Low schooling 2.15 (0.98–4.75) 0.057 1.22 (0.52–2.88) 0.650 0.754
Sub-Saharian Africa/Arabian/Other origin 3.8 (1.65–8.75) < 0.05 2.71 (1.07–6.82) < 0.05 0.061
PRHDs 6.54 (2.25–19.03) < 0.05 1.06 (0.35–3.26) 0.920 0.918
Gestational age at birth (weeks) (ŧ) 0.68 (0.63–0.72) < 0.05 0.66 (0.6–0.73) < 0.05 < 0.05
Prenatal RDS prophylaxis (ŧ) 7.42 (4.95–11.13) < 0.05 0.06 (0.00–1.00) 0.050 0.070
Fetal IVH (3rd-4th degree)
Maternal age < 17 years or > 40 years 2.69 (1.31–5.53) < 0.05 2.97 (1.24–7.14) < 0.05 < 0.05
Nulliparous women 1.49 (0.84–2.64) 0.17
Conception via assisted reproductive
techniques
2.61 (0.63–10.75) 0.185
Low schooling 1.49 (0.83–2.68) 0.184
Sub-Saharian Africa origin 2.86 (1.22–6.71) < 0.05 1.59 (0.59–4.28) 0.360 0.481
PRHDs 2.99 (1.08–8.33) < 0.05 0.71 (0.24–2.1) 0.530 0.533
Gestational age at birth (weeks) 0.62 (0.58–0.66) < 0.05 0.62 (0.58–0.66) < 0.05 < 0.05
Acronyms: PRHD Pregnancy related hypertensive disorder, PVL Periventricular leucomalacia, RDS Respiratory distress syndrome, IVH Intraventricular hemorrhage.
Interaction terms: (ŧ) Interaction term for gestational age at birth and prenatal RDS prophylaxis OR 1.12 (CI95% 1.02–1.23) (p < 0.05)
Londero et al. BMC Pregnancy and Childbirth          (2019) 19:261 Page 8 of 10
Conclusions
In spite of the underlying mechanisms, these findings
confirm the negative impact of extreme maternal ages
on pregnancy. As the trend of delaying childbearing is
well-established and likely to continue, these results
should be carefully taken into account by maternal care
providers in order to inform women adequately, provid-
ing evidence-based knowledge to support their procre-
ation choices, and to improve clinical surveillance
aiming to identify early signs of adverse outcomes.
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